Cell Therapy with Embryonic Stem Cell-Derived Cardiomyocytes Encapsulated in Injectable Nanomatrix Gel Enhances Cell Engraftment and Promotes Cardiac Repair

[Image: see text] A significant barrier to the therapeutic use of stem cells is poor cell retention in vivo. Here, we evaluate the therapeutic potential and long-term engraftment of cardiomyocytes (CMs) derived from mouse embryonic stem cells (mESCs) encapsulated in an injectable nanomatrix gel cons...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ban, Kiwon, Park, Hun-Jun, Kim, Sangsung, Andukuri, Adinarayana, Cho, Kyu-Won, Hwang, Jung Wook, Cha, Ho Jin, Kim, Sang Yoon, Kim, Woan-Sang, Jun, Ho-Wook, Yoon, Young-Sup
Formato: Artigo
Lenguaje:Inglês
Publicado: American Chemical Society 2014
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4212793/
https://ncbi.nlm.nih.gov/pubmed/25210842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/nn504617g
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares